Infectious: Page 2

Cytokine improves outcomes in mice with sepsis, predicts survival in humans

By Nick Paul Taylor

Administering a protein that correlates to survival in sepsis has improved survival in mice in a study, pointing to a potential new way to treat the life-threatening reaction to infection.

February 6, 2024

U.K. Health Security Agency unveils five-year pathogen genomics strategy

By Matt Limb

The U.K. Health Security Agency (UKHSA) has unveiled a five-year plan to make pathogen genomics central to protecting public health and combating infectious disease threats.

February 1, 2024

Program to fight sepsis in LMICs launched at SCCM Congress, test data presented

By Matt Limb

Intensive care professionals have unveiled a program to cut deaths from sepsis in low- and middle-income countries (LMICs) with ambitions to improve access to diagnostic tools, laboratories, and medicines.

January 26, 2024

Concentric by Ginkgo, Illumina to collaborate on biosurveillance technology

By Matt Limb

Illumina and biosecurity firm Concentric by Ginkgo have pledged to expand biosecurity capabilities to help countries “modernize defenses" against emerging biological threats.

January 24, 2024

NowDiagnostics submits FDA de novo request for OTC syphilis test

By LabPulse.com staff writers

NowDiagnostics has submitted a de novo authorization request to the U.S. Food and Drug Administration (FDA) for its First to Know over-the-counter (OTC) syphilis test.

January 10, 2024

FDA grants priority review to Merck’s pneumococcal vaccine

By LabPulse.com staff writers

The U.S. Food and Drug Administration (FDA) has granted priority review to Merck’s experimental pneumococcal vaccine, with a decision to be made on approval by June 17, 2024.

December 20, 2023

AstraZeneca to buy Icosavax in agreement worth up to $1.1B

By LabPulse.com staff writers

AstraZeneca has agreed to buy vaccine developer Icosavax in a deal worth up to $1.1 billion.

December 13, 2023

CDC awards contract to Quest Diagnostics to assess hepatitis C burden

By LabPulse.com staff writers

Quest Diagnostics has been awarded a multiyear contract by the U.S. Centers for Disease Control and Prevention (CDC) to assess the burden of hepatitis C virus (HCV) in the U.S.

December 7, 2023

U.K. researchers use deep learning to develop rapid antimicrobial resistance test

By Matt Limb

Researchers are hailing progress toward more rapid detection of antimicrobial resistance (AMR), with a susceptibility test returning results in 30 minutes.

December 1, 2023

Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test

By LabPulse.com staff writers

Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.

November 22, 2023

Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution

By Matt Limb

Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.

November 20, 2023

Cytovale raises $84M in series C funding

By LabPulse.com staff writers

Medical technology firm Cytovale has raised $84 million in a series C financing round that the firm says it will use to expand the commercialization of its 10-minute IntelliSep test.

November 16, 2023

Previous Page

Page 2 of 150

Next Page